As of 2026-01-11, the Relative Valuation of Pfizer Inc (PFE) is 34.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.48 USD, the upside of Pfizer Inc based on Relative Valuation is 35.7%.
The range of the Relative Valuation is 25.22 - 50.10 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 29.0x | 24.7x |
| Forward P/E multiples | 19.2x - 20.9x | 20.1x |
| Fair Price | 25.22 - 50.10 | 34.58 |
| Upside | -1.0% - 96.6% | 35.7% |
| Date | P/E |
| 2026-01-09 | 14.74 |
| 2026-01-08 | 14.63 |
| 2026-01-07 | 14.62 |
| 2026-01-06 | 14.71 |
| 2026-01-05 | 14.56 |
| 2026-01-02 | 14.57 |
| 2025-12-31 | 14.40 |
| 2025-12-30 | 14.46 |
| 2025-12-29 | 14.46 |
| 2025-12-26 | 14.51 |
| 2025-12-24 | 14.48 |
| 2025-12-23 | 14.39 |
| 2025-12-22 | 14.58 |
| 2025-12-19 | 14.57 |
| 2025-12-18 | 14.48 |
| 2025-12-17 | 14.48 |
| 2025-12-16 | 14.77 |
| 2025-12-15 | 15.29 |
| 2025-12-12 | 14.95 |
| 2025-12-11 | 14.92 |
| 2025-12-10 | 14.91 |
| 2025-12-09 | 14.65 |
| 2025-12-08 | 14.91 |
| 2025-12-05 | 15.06 |
| 2025-12-04 | 14.87 |
| 2025-12-03 | 14.79 |
| 2025-12-02 | 14.55 |
| 2025-12-01 | 14.62 |
| 2025-11-28 | 14.89 |
| 2025-11-26 | 14.87 |
| 2025-11-25 | 14.88 |
| 2025-11-24 | 14.59 |
| 2025-11-21 | 14.48 |
| 2025-11-20 | 14.11 |
| 2025-11-19 | 14.39 |
| 2025-11-18 | 14.72 |
| 2025-11-17 | 14.51 |
| 2025-11-14 | 14.50 |
| 2025-11-13 | 14.92 |
| 2025-11-12 | 14.96 |
| 2025-11-11 | 14.76 |
| 2025-11-10 | 14.11 |
| 2025-11-07 | 14.13 |
| 2025-11-06 | 14.37 |
| 2025-11-05 | 14.24 |
| 2025-11-04 | 14.06 |
| 2025-11-03 | 14.26 |
| 2025-10-31 | 14.26 |
| 2025-10-30 | 14.05 |
| 2025-10-29 | 14.05 |